Company Filing History:
2 out of 15,475 
1 out of 388 
1 out of 4 Years Active: 2012-2017
Title: Innovations of Lee-way Jin in Alzheimer's Disease Research
Introduction
Lee-way Jin is an accomplished inventor based in Davis, California, known for his significant contributions to the field of Alzheimer's disease research. With a total of two patents to his name, Jin has focused on developing compounds that address the challenges posed by amyloid beta aggregates, which are implicated in the progression of Alzheimer's disease.
Latest Patents
Jin's latest patents include innovative compounds designed to reduce amyloid beta aggregates. The first patent details tricyclic pyrone compounds that exhibit high oral bioavailability, excellent blood-brain barrier permeability, and low toxicity. These compounds have shown promise in transgenic models of Alzheimer's disease, resulting in a substantial reduction of both soluble and insoluble amyloid beta species in the brain, without adversely affecting general behavior and motor coordination. Additionally, these compounds block the toxicity and formation of both intraneuronal and extracellular amyloid beta aggregates, while also enhancing cellular cholesterol efflux, restoring axonal trafficking, and improving hippocampal synaptic plasticity. The second patent focuses on Aβ-binding small molecules, providing compounds and labeled compounds for therapeutic and imaging purposes, particularly in treating Alzheimer's disease and imaging amyloid beta peptide aggregates in patients.
Career Highlights
Throughout his career, Lee-way Jin has worked with prestigious institutions, including the University of California and the Kansas State University Research Foundation. His research has significantly advanced the understanding of Alzheimer's disease and the development of potential therapeutic interventions.
Collaborations
Jin has collaborated with notable colleagues, including Izumi Maezawa and Duy H Hua, contributing to a rich exchange of ideas and expertise in the field of neurodegenerative diseases.
Conclusion
Lee-way Jin's innovative work in developing compounds to combat Alzheimer's disease highlights his dedication to addressing critical health challenges. His patents represent a significant step forward in the search for effective treatments for this debilitating condition.